• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by LogicMark Inc.

    8/7/24 8:20:26 PM ET
    $LGMK
    Industrial Specialties
    Health Care
    Get the next $LGMK alert in real time by email
    SC 13D/A 1 ea0210831-13da1simmons_logic.htm AMENDMENT NO. 1 TO SCHEDULE 13D

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

    LogicMark, Inc.
    (Name of Issuer)

     

    Common Stock, par value $0.0001 per share
    (Title of Class of Securities)

     

    67091J503
    (CUSIP Number)

     

    David E. Danovitch, Esq.

    Sullivan & Worcester LLP

    1251 Avenue of the Americas

    New York, NY 10020

    (212) 660-3000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
     
    August 5, 2024
    (Date of Event which Requires Filing of this Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this Schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    CUSIP No. 67091J503 13D Page 2 of 5 Pages

     

    1

    names of reporting persons

     

    Chia-Lin Simmons

     
    2

    check the appropriate box if a member of a group*

     

    (a) ☐

     

    (b) ☐

    3

    sec use only

     

     
    4

    source of funds*

     

    OO (1)

     
    5

    check if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e)

     

     

    ☐
    6

    citizenship or place of organization

     

    United States

     

    number of
    shares
    beneficially
    owned by
    each
    reporting
    person
    with
    7

    sole voting power

     

    153,222 (1)

     
    8

    shared voting power

     

    0

     
    9

    sole dispositive power

     

    153,222 (1)

     
    10

    shared dispositive power

     

    0

     

    11

    aggregate amount beneficially owned by each reporting person

     

    153,222 (1)

     
    12

    check if the aggregate amount in row (11) excludes certain shares*

     

    ☐
    13

    percent of class represented by amount in row (11)

     

    3.5% (1)

     
    14

    type of reporting person*

     

    IN

     

     

    *SEE INSTRUCTIONS

     

    (1)This constitutes an exit filing for Chia-Lin Simmons (the “Reporting Person”). As more fully described in Item 5 of this Amendment No. 1 to Statement on Schedule 13D (this “Amendment No. 1”), such shares and percentages are based on 4,412,812 shares of common stock, par value $0.0001 per share (“Common Stock”), of LogicMark, Inc. (the “Issuer”), issued and outstanding, as verified with the Issuer, and includes an aggregate of 131,736 shares of Common Stock granted by the Issuer to the Reporting Person as restricted stock awards for the Reporting Person’s services as Chief Executive Officer and President of the Issuer, certain of which shares are subject to vesting, as described in Item 6 of Statement on Schedule 13D filed by the Reporting Person with the U.S. Securities and Exchange Commission (the “SEC”) on April 5, 2024 (the “Schedule 13D”), subject to the Reporting Person’s continued service through each such vesting date.

     

     

     

    CUSIP No. 67091J503 13D Page 3 of 5 Pages

     

    This Amendment No. 1 amends and supplements the Schedule 13D filed by the Reporting Person with the SEC on April 5, 2024. Except as otherwise set forth herein, this Amendment No. 1 does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used but not defined in this Amendment No. 1 shall have the meanings ascribed to such terms in the Schedule 13D.

     

    The purpose of this Amendment No. 1 is to update the disclosure of the Schedule 13D, including the beneficial ownership information on the cover pages and in Items 3, 4, 5 and 6 of the Schedule 13D, and to indicate that the Reporting Person has ceased to be the beneficial owner of more than five percent of the shares of the outstanding Common Stock of the Issuer. This Amendment No. 1 constitutes an exit filing for the Reporting Person.

     

    Item 1. Security and Issuer.

     

    The information contained in “Item 1. Security and Issuer.” of the Schedule 13D is not being amended by this Amendment No. 1.

     

    Item 2. Identity and Background.

     

    The information contained in “Item 2. Identity and Background.” of the Schedule 13D is not being amended by this Amendment No. 1.

     

    Item 3. Source or Amount of Funds or Other Consideration.

     

    “Item 3. Source or Amount of Funds or Other Consideration.” of the Schedule 13D is hereby amended and restated in its entirety as follows:

     

    The Reporting Person beneficially owns 153,222 shares of Common Stock, of which (i) 13,328 shares of Common Stock were granted to the Reporting Person as a material inducement to employment in accordance with Nasdaq Listing Rule 5635(c)(4) outside of the Issuer’s stock incentive plans, (ii) 118,408 shares of Common Stock were granted pursuant to the Issuer’s stock incentive plans as compensation for the Reporting Person’s service as Chief Executive Officer and President of the Issuer, and (iii) 21,486 shares of Common Stock were purchased by the Reporting Person from the Issuer using the Reporting Person’s personal funds in connection with the Issuer’s offering of its units (the “Units”) and pre-funded units pursuant to the Issuer’s registration statement on Form S-1, as amended (File No. 333-279133), declared effective by the SEC on August 1, 2024 (the “Offering”).

     

    Item 4. Purpose of Transaction.

     

    The Reporting Person is the Chief Executive Officer and President of the Issuer, as well as a member of the Issuer’s board of directors. Other than the 21,486 shares of the Common Stock acquired by the Reporting Person in the Offering, all of the Issuer’s shares of Common Stock owned by the Reporting Person have been acquired or granted to the Reporting Person by the Issuer in her capacity as an officer of the Issuer, as further described in Item 6 of the Schedule 13D.

     

    As further described in Item 6 of this Amendment No. 1, the Issuer closed the Offering of its units and pre-funded units on August 5, 2024, pursuant to which, among other purchases by participants in the Offering, the Reporting Person purchased (i) 21,486 Units at an offering price of $0.4654 per Unit, with each Unit consisting of (i) one share of Common Stock, (ii) one Series A warrant to purchase Common Stock exercisable for one share of Common Stock (the “Series A Warrants”), and (iii) one Series B warrant to purchase Common Stock exercisable for one share of Common Stock (the “Series B Warrants”, and, together with the Series A Warrants, the “Warrants”). The Warrants issued in the Offering, including those purchased and held by the Reporting Person, are only exercisable on or after the date on which the Issuer obtains the approval of its stockholders for the issuance of all shares of Common Stock issuable upon exercise of the Warrants in the Offering, solely to the extent such approval is required by Rule 5635(d) of The Nasdaq Stock Market LLC (the “Stockholder Approval”).

     

    The information contained in rows (7), (8), (9), (10), (11) and (13) of the cover page of this Amendment No. 1 and the corresponding footnotes, and the information set forth in or incorporated by reference in Items 2, 3, 5 and 6 of this Amendment No. 1 is hereby incorporated by reference in its entirety into this Item 4.

     

    Except as described above, the information contained in “Item 4. Purpose of Transaction.” of the Schedule 13D is not being amended by this Amendment No. 1.

     

     

     

    CUSIP No. 67091J503 13D Page 4 of 5 Pages

     

    Item 5. Interest in Securities of the Issuer.

     

    “Item 5. Interest in Securities of the Issuer.” of the Schedule 13D is hereby amended and restated in its entirety as follows:

     

    The responses to rows (7) through (13) of the cover page of this Amendment No. 1 and the corresponding footnotes are hereby incorporated by reference in their entirety in this Item 5.

     

    (a)See responses to rows (11) and (13) on the cover page.

     

    (b)See response to rows (7), (8), (9) and (10) on the cover page.

     

    (c)Except as described further in Item 6 with respect to the Reporting Person’s participation in the Offering, the Reporting Person has not, to the best of her knowledge, engaged in any transaction with respect to the Common Stock during the sixty days prior to the date of filing this Amendment No. 1.

     

    (d)To the knowledge of the Reporting Person, no person other than the Reporting Person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock of the Issuer beneficially owned by the Reporting Person as reported in the Schedule 13D.

     

    (e)On August 5, 2024, the Reporting Person ceased to be the beneficial owner of more than five percent of the outstanding shares of Common Stock.

     

    Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

     

    In connection with the Offering, the Reporting Person purchased from the Issuer 21,486 Units at an offering price of $0.4654 per Unit, consisting of (i) 21,486 shares of Common Stock at an offering price of $0.4554 per share, (ii) 21,486 Series A Warrants exercisable for up to 21,486 shares of Common Stock, and (iii) 21,486 Series B Warrants exercisable for up to 21,486 shares of Common Stock. Each of the Warrants held by the Reporting Person are only exercisable on or after the date of Stockholder Approval, and as a result, the 42,972 shares of Common Stock issuable upon full exercise of such Warrants are not deemed to be beneficially owned by the Reporting Person, as the Reporting Person does not have the right to acquire such shares within sixty days of the date of this Amendment No. 1. Additionally, in connection with the Offering, on July 30, 2024, the Reporting Person entered into a lock-up agreement with the Issuer (the “Lock-Up Agreement), preventing the offer, sale or other disposition of the shares Common Stock, Warrants, and any other securities of the Issuer held by the Reporting Person that are convertible, exchangeable or exercisable into shares of Common Stock, for a period of 60 days from the date of the closing of the Offering, subject to certain exceptions contained therein.

     

    Except as described above, the information contained in “Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.” of the Schedule 13D is not being amended by this Amendment No. 1.

     

    Item 7. Material to be filed as Exhibits.

     

    The foregoing summary of the Lock-Up Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Lock-Up Agreement, the form of which is filed as Exhibit A to the form of placement agency agreement, by and between the Company and the placement agent for the Offering, which placement agency agreement is filed as Exhibit 1.1 to the Issuer’s registration statement on Form S-1, as amended (File No. 333-279133), filed with the SEC on June 20, 2024, and which Lock-Up Agreement is incorporated by reference into this Item 7.

     

    Except as described above, the information contained in “Item 7. Material to be filed as Exhibits.” of the Schedule 13D is not being amended by this Amendment No. 1.

      

     

     

    CUSIP No. 67091J503 13D Page 5 of 5 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: August 7, 2024  
       
      /s/ Chia-Lin Simmons
      Name: Chia-Lin Simmons

     

     

     

     

    Get the next $LGMK alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $LGMK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LGMK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Schneider Carine

      4 - LogicMark, Inc. (0001566826) (Issuer)

      7/2/25 7:07:33 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • SEC Form 4 filed by Director Curtis Robert Arthur

      4 - LogicMark, Inc. (0001566826) (Issuer)

      7/2/25 7:07:19 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • SEC Form 4 filed by Director Gutierrez Barbara

      4 - LogicMark, Inc. (0001566826) (Issuer)

      7/2/25 7:07:05 PM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    SEC Filings

    See more
    • SEC Form PRE 14A filed by LogicMark Inc.

      PRE 14A - LogicMark, Inc. (0001566826) (Filer)

      6/30/25 8:04:24 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark Inc. filed SEC Form 8-K: Shareholder Director Nominations

      8-K - LogicMark, Inc. (0001566826) (Filer)

      6/26/25 4:05:28 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - LogicMark, Inc. (0001566826) (Filer)

      6/2/25 8:45:20 AM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Large owner Winvest Investment Fund Management Corp. bought $114,112 worth of shares (1,257,257 units at $0.09), increasing direct ownership by 34% to 4,074,587 units (SEC Form 4)

      4/A - LogicMark, Inc. (0001566826) (Issuer)

      11/12/24 3:46:00 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • Large owner Winvest Investment Fund Management Corp. bought $306,880 worth of shares (3,464,987 units at $0.09), increasing direct ownership by 331% to 4,074,587 units (SEC Form 4)

      4 - LogicMark, Inc. (0001566826) (Issuer)

      10/18/24 9:31:15 PM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • LogicMark, Inc. Appoints Jeffrey Durkin as Senior Vice President of Sales to Drive Strategic Growth in the Care Economy and Personal Safety Markets

      LOUISVILLE, Ky, June 17, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (the "Company"), a provider of personal emergency response systems (PERS), health communication devices, and technology for the growing safety and care economy, announced the appointment of Jeffrey Durkin, as Senior Vice President of Sales effective June 23, 2025. Mr. Durkin previously held sales and marketing roles with InfoMC, Casenet, InstaMed, HMS, and Allscripts. He holds a Master of Business Administration from Anna Maria College and a Bachelor of Science in Marketing from Fitchburg State University. In his new role, Mr. Durkin will lead the sales team at LogicMark and drive significant growth for the company in the c

      6/17/25 9:00:00 AM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark, Inc. Common Stock to Commence Trading on OTC Markets as the Company Continues Advancing Growth Initiatives

      LOUISVILLE, Ky., June 02, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (the "Company"), a provider of personal emergency response systems ("PERS"), health communication devices, and technology for the growing care economy, today announced that it expects that its common stock will begin trading on the over-the-counter markets ("OTC Markets"), effective today. The move to OTC Markets follows Nasdaq's decision to delist the Company's common stock at the opening of trading today, due solely to the Company's non-compliance with Nasdaq's $1.00 minimum bid price requirement. Chia-Lin Simmons, CEO of LogicMark, emphasized the importance of this transition, stating, "The ability to continue quotation

      6/2/25 8:30:00 AM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark, Inc. Unveils New Board Committee Leadership Structure to Align with Strategic Goals

      LOUISVILLE, Ky., April 28, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK) (the "Company"), a provider of personal emergency response systems (PERS), health communication devices, and technology for the growing care economy, today announced changes to its Board committee assignments. The LogicMark Board of Directors maintains an Audit Committee, a Compensation Committee, and a Nominating and Corporate Governance Committee. The Board comprises four independent non-executive directors who serve on the Committees and the Company's Chief Executive Officer (CEO), totaling five directors. The following new Board committee assignments reflect LogicMark's ongoing efforts to ensure that it

      4/28/25 9:00:00 AM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    Leadership Updates

    Live Leadership Updates

    See more
    • LogicMark, Inc. Appoints Jeffrey Durkin as Senior Vice President of Sales to Drive Strategic Growth in the Care Economy and Personal Safety Markets

      LOUISVILLE, Ky, June 17, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (the "Company"), a provider of personal emergency response systems (PERS), health communication devices, and technology for the growing safety and care economy, announced the appointment of Jeffrey Durkin, as Senior Vice President of Sales effective June 23, 2025. Mr. Durkin previously held sales and marketing roles with InfoMC, Casenet, InstaMed, HMS, and Allscripts. He holds a Master of Business Administration from Anna Maria College and a Bachelor of Science in Marketing from Fitchburg State University. In his new role, Mr. Durkin will lead the sales team at LogicMark and drive significant growth for the company in the c

      6/17/25 9:00:00 AM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark Expands its Board of Directors by Naming Carine Schneider and Tom Wilkinson as Company's Innovative Product Pipeline Continues to Grow (Updated with Additional Details)

      LOUISVILLE, Ky., Oct. 31, 2023 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK) (the "Company"), creator of the most innovative personal safety and security technology designed for the care economy, today announced that Carine Schneider, FGE, and Tom Wilkinson will join as the newest members of its Board of Directors. Ms. Schneider and Mr. Wilkinson both bring decades of corporate governance, finance, operations, technology, M&A, advisory and CEO experience. "I am thrilled to welcome Carine and Tom to our Board of Directors. Carine's demonstrated history of leadership and innovation in the technology and finance sectors, coupled with Tom's extensive experience and influential work with a

      10/31/23 11:54:15 AM ET
      $ASTC
      $LGMK
      $SONM
      Biotechnology: Laboratory Analytical Instruments
      Industrials
      Industrial Specialties
      Health Care
    • Carine Schneider and Tom Wilkinson Join LogicMark's Board of Directors to Help Accelerate Growth

      LOUISVILLE, Ky., Oct. 31, 2023 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK) (the "Company"), creator of the most innovative personal safety and security technology designed for the care economy, today announced that Carine Schneider, FGE, and Tom Wilkinson will join as the newest members of its Board of Directors. Ms. Schneider and Mr. Wilkinson both bring decades of financial services, international business, and consulting experience. "I am thrilled to welcome Carine and Tom to our Board of Directors. Carine's demonstrated history of leadership and innovation in the technology and finance sectors, coupled with Tom's extensive experience and influential work with a variety of succes

      10/31/23 8:00:00 AM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by LogicMark Inc.

      SC 13D/A - LogicMark, Inc. (0001566826) (Subject)

      12/3/24 3:35:39 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • SEC Form SC 13G filed by LogicMark Inc.

      SC 13G - LogicMark, Inc. (0001566826) (Subject)

      11/14/24 5:58:26 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • Amendment: SEC Form SC 13D/A filed by LogicMark Inc.

      SC 13D/A - LogicMark, Inc. (0001566826) (Subject)

      11/12/24 3:45:20 PM ET
      $LGMK
      Industrial Specialties
      Health Care

    $LGMK
    Financials

    Live finance-specific insights

    See more
    • LogicMark, Inc. Reports Strong Third-Quarter 2024 Results Led by Double-Digit Growth in Year-Over-Year Sales and Gross Profit

      LOUISVILLE, Ky., Nov. 12, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK), a provider of personal safety, emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, today announced financial results for the third quarter ended September 30, 2024. Financial and Operational Highlights: Revenues rose to $2.7 million in the third quarter of 2024, a 14% year-over-year increase.Gross profit increased to $1.8 million, a 13% increase over the third quarter of 2023.Gross margin was 67%, a level consistently maintained over the past six quarters.Overall operating expenses were $3.4 million, flat with the prior year period. Chia

      11/12/24 4:05:00 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark, Inc. Announces Adoption of Shareholder Rights Agreement

      LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK), ("LogicMark" or the "Company"), a provider of personal safety, emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, today announced that it has entered into a Rights Agreement with Nevada Agency and Transfer Company (the "Rights Agreement") to protect shareholder rights and long-term shareholder value. This decision has been taken in response to recent actions by Winvest Investment Fund Management Corp. ("Winvest"), which recently disclosed in public filings with the U.S. Securities and Exchange Commission ("SEC") that it (i) purportedly ow

      11/1/24 4:44:26 PM ET
      $LGMK
      Industrial Specialties
      Health Care
    • LogicMark, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024

      LOUISVILLE, Ky., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ:LGMK), a provider of emergency response systems, health communications devices, and technology for the growing personal safety and care economy, will issue a press release announcing its financial results for the third quarter ended September 30, 2024, after the market close on Tuesday, November 12, 2024. Ms. Chia-Lin Simmons, CEO, and Mr. Mark Archer, CFO, will host a live investor call and webcast the same day at 1:30 PM (PST) / 4:30 PM (EST) to review the results. Investors and analysts wishing to participate in the conference call must dial in here: Participant Toll-Free Dials: (800) 715-9871Participant Toll D

      10/31/24 9:15:49 AM ET
      $LGMK
      Industrial Specialties
      Health Care